ZIM
RGEN icon

Zacks Investment Management’s Repligen RGEN Stock Holding History

Zacks Investment Management’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-18,355
Closed -$3.45M – 634
2022
Q1 		$3.45M Buy
18,355
+399
+2% +$75.8K 0.05% 219
2021
Q4 		$4.76M Buy
17,956
+107
+0.6% +$28.8K 0.07% 192
2021
Q3 		$5.16M Buy
17,849
+403
+2% +$103K 0.08% 182
2021
Q2 		$3.48M Buy
17,446
+4,511
+35% +$875K 0.06% 215
2021
Q1 		$2.51M Buy
12,935
+1,814
+16% +$372K 0.04% 251
2020
Q4 		$2.13M Buy
11,121
+7,112
+177% +$1.29M 0.04% 253
2020
Q3 		$591K Buy
4,009
+600
+18% +$85.8K 0.01% 387
2020
Q2 		$421K Buy
+3,409
New +$401K 0.01% 407

Other funds holding RGEN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Zacks Investment Management's RGEN Position: Q2 2022 in Review

Zacks Investment Management sold out of Repligen (RGEN) in Q2 2022, closing a stake of 18,355 shares — an estimated $3.45M sold.

Zacks Investment Management first reported a position in RGEN in Q2 2020 and held it in 8 quarters. The position peaked at $5.16M in Q3 2021. 405 funds tracked by Wall St. Rank hold RGEN as of Q2 2022.

  • Zacks Investment Management reported no remaining Repligen position as of Q2 2022 after selling out during the quarter.
  • Zacks Investment Management sold 18,355 Repligen shares in Q2 2022, an estimated $3.45M.
  • Zacks Investment Management first reported a position in Repligen in Q2 2020 and held it in 8 quarters.
  • Zacks Investment Management's Repligen position peaked at $5.16M in Q3 2021.
  • 405 funds tracked by Wall St. Rank held Repligen as of Q2 2022.

Based on Zacks Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.